Recombinant VEGFR2 (Olinvacimab Biosimilar) antibody

Catalog No. ABIN7676033

The Human Monoclonal anti-VEGFR2 (Olinvacimab Biosimilar) antibody is suitable to detect VEGFR2 (Olinvacimab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant VEGFR2 (Olinvacimab Biosimilar) antibody (ABIN7676033)

Target: VEGFR2 (Olinvacimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This VEGFR2 (Olinvacimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-VEGFR2 (Olinvacimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab)

Characteristics: Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for VEGFR2 (Olinvacimab Biosimilar)

Target: VEGFR2 (Olinvacimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P35968